Cargando…
Biological therapy for ulcerative colitis
Ulcerative colitis (UC) is a major form of inflammatory bowel disease (IBD) worldwide. Better understanding of the pathogenesis of UC has led to the development of novel therapeutic agents that target specific mediators of the inflammatory cascade. A number of biological agents have been approved by...
Autores principales: | Arora, Zubin, Shen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423460/ https://www.ncbi.nlm.nih.gov/pubmed/25344680 http://dx.doi.org/10.1093/gastro/gou070 |
Ejemplares similares
-
Risk factors and clinical implication of superimposed Campylobacter jejuni infection in patients with underlying ulcerative colitis
por: Arora, Zubin, et al.
Publicado: (2016) -
Current and Emerging Biologics for Ulcerative Colitis
por: Park, Sung Chul, et al.
Publicado: (2015) -
Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis
por: Reznicek, Emily, et al.
Publicado: (2021) -
Medical Therapy of Active Ulcerative Colitis
por: Bürger, Martin, et al.
Publicado: (2015) -
Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum
por: Lee, Hae Chan, et al.
Publicado: (2023)